KC
NVO

Kingfisher Capital’s Novo Nordisk NVO Stock Holding History

Kingfisher Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$321K Sell
2,693
-200
-7% -$26.7K 0.07% 146
2024
Q2 		$413K Buy
2,893
+893
+45% +$118K 0.1% 125
2024
Q1 		$257K Hold
2,000
– – 0.06% 146
2023
Q4 		$207K Buy
+2,000
New +$198K 0.05% 161
2016
Q1 		– Sell
-45,650
Closed -$1.33M – 218
2015
Q4 		$1.33M Buy
45,650
+3,218
+8% +$89.1K 0.78% 57
2015
Q3 		$1.15M Sell
42,432
-398
-0.9% -$11.3K 0.73% 63
2015
Q2 		$1.17M Sell
42,830
-26,636
-38% -$749K 0.68% 71
2015
Q1 		$1.85M Buy
69,466
+800
+1% +$18.4K 0.96% 35
2014
Q4 		$1.45M Buy
68,666
+2,860
+4% +$63.9K 0.74% 65
2014
Q3 		$1.57M Sell
65,806
-676
-1% -$15.6K 0.84% 44
2014
Q2 		$1.53M Sell
66,482
-8,264
-11% -$182K 0.8% 51
2014
Q1 		$1.71M Sell
74,746
-384
-0.5% -$8.18K 0.9% 42
2013
Q4 		$1.39M Sell
75,130
-2,600
-3% -$45.3K 0.75% 54
2013
Q3 		$1.31M Sell
77,730
-1,700
-2% -$28.6K 0.67% 59
2013
Q2 		$1.23M Buy
+79,430
New +$1.32M 0.68% 62

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Kingfisher Capital's NVO Position: Q3 2024 in Review

Kingfisher Capital reduced its Novo Nordisk (NVO) stake by 6.9% in Q3 2024, selling an estimated $26.7K and leaving 2,693 shares worth $321K. The position accounts for 0.07% of the portfolio, ranked #146.

Kingfisher Capital first reported a position in NVO in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.85M in Q1 2015. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Kingfisher Capital held 2,693 shares of Novo Nordisk worth $321K as of Q3 2024.
  • Kingfisher Capital sold 200 Novo Nordisk shares in Q3 2024, an estimated $26.7K.
  • Novo Nordisk made up 0.07% of Kingfisher Capital's portfolio in Q3 2024, its #146 holding.
  • Kingfisher Capital first reported a position in Novo Nordisk in Q2 2013 and has held it in 15 quarters since.
  • Kingfisher Capital's Novo Nordisk position peaked at $1.85M in Q1 2015.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Kingfisher Capital's 13F filing for Q3 2024, filed 14 Nov 2024.